Assort Health Funding: $222M Raised, Series C (2026)
Assort Health is a Healthtech company based in San Francisco. It has raised $222M in total funding. Latest round: Series C.
Assort Health funding overview
Assort Health is a Healthtech company based in San Francisco. Assort Health has raised $222M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in June 2026. The round record for Assort Health runs through 2026; nothing later has been disclosed. Investors on record include Menlo Ventures, Lightspeed Venture Partners, First Round Capital, Chemistry, Felicis, Quiet Capital and 6 others. 12 distinct backers are named across the disclosed rounds.
Assort Health at a glance
Total raised
$222M
Latest round
Series C
Latest round date
June 2026
Industry
Healthtech
Headquarters
San Francisco
Notable investors
Menlo Ventures, Lightspeed Venture Partners, First Round Capital, Chemistry, Felicis, Quiet Capital, Tau Ventures, Four Acres
Frequently asked about Assort Health funding
How much has Assort Health raised?
Assort Health has raised $222M in total disclosed funding across the rounds on record.
Who has invested in Assort Health?
Menlo Ventures, Lightspeed Venture Partners, First Round Capital, Chemistry, Felicis, Quiet Capital are named among the investors backing Assort Health.
What was the latest Assort Health funding round?
The most recent disclosed round is a Series C, announced in June 2026.
Where is Assort Health based?
Assort Health is based in San Francisco.
What sector does Assort Health operate in?
Assort Health is tracked under Healthtech from San Francisco, with $222M in disclosed funding.
When did Assort Health last raise?
The last disclosed Assort Health round closed in June 2026 at Series C.
Assort Health totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in San Francisco below to benchmark round size and investor mix.
